← All stocks

ImageneBio, Inc.

IMA Net buying
CIK 0001835579 #4590 in the set updated 20 Sep 2026
Bought (120 mo)
$30.40M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$815.24K
$0.00 on a plan · $26.76K straight out of an exercise
Sold at will
$788.48K
8 of 11 sales
Net
+$29.59M
+$29.61M against sales at will

By person

16 insiders · 31 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Bonita David P
Director
$10.40M (7)
+$10.40M
419,188
$2.24M
Stampacchia Otello
Director
$8.00M (1)
+$8.00M
2,704,484
$14.44M
+1,343%
ORBIMED ADVISORS LLC entity
Director
$7.90M (6)
+$7.90M
418,809
$2.24M
Atlas Venture Fund XI, L.P. entity
10% owner
$2.00M (1)
$385.57K (3)
+$1.61M
2,116,569
$11.30M
+4.9%
FORMELA JEAN FRANCOIS
Director
$2.00M (1)
$385.57K (3)
+$1.61M
1,991,569
$10.63M
SLATTERY JOSEPH P
Director
$95.84K (1)
+$95.84K
16,000
$85.44K
Zhang Xiaoyan Michelle
Chief Scientific Officer
$26.76K (3) scheduled
−$26.76K
44,475
$237.50K
0.0%
Lally Robert B
Principal Accounting Officer
$17.33K (2)
−$17.33K
55,582
$296.81K
−5.4%
Wang Jonathan Jian
Director
1,115,005
$5.95M
Atlas Venture Fund X, L.P. entity
10% owner
749,634
$4.00M
Yarema Kristin
Chief Executive Officer
493,705
$2.64M
Grant-Huerta Yanina
Chief Financial Officer
104,000
$555.36K
Tessier Maude
Chief Business Officer
100,578
$537.09K
+249.3%
Butler Erin
Principal Accounting Officer
25,551
$136.44K
Wang Stephen Hui
Director
12,535
$66.94K
Marango Jotin
Chief Financial Officer
11,146
$59.52K

No percentages here. This company's share count has moved by a factor of 4.3 over the window, from 11,181,672 to 48,258,111 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Zhang Xiaoyan Michelle
11 Jan 2022
Chief Scientific Officer
Sold after exercise
964
$12.00
$11.57K
Zhang Xiaoyan Michelle
10 Jan 2022
Chief Scientific Officer
Sold after exercise
36
$12.00
$432.00
Zhang Xiaoyan Michelle
10 Dec 2021
Chief Scientific Officer
Sold after exercise
1,000
$14.76
$14.76K

What was left out

Form 4 filings counted 85
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 3
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 28,423,224
Sales filed before the plan box existed 6
History held since 1 Apr 2021